Venkatesan A, Chen R, Bär M, Schneeberger P.H.H, Reimer B, Hürlimann E, Coulibaly J.T, Ali S.M, Sayasone S, Soghigian J, Keiser J, Gilleard J.S. Trichuriasis in human patients from Côte d'Ivoire Caused by Novel Trichuris incognita species with low sensitivity to albendazole/ivermectin combination treatment. Emerg Infect Dis. 2025;31(1):104-114. DOI: 10.3201/eid3101.240995

2025
Journal Article
PubMed

Ajayi D.T, Orherhe O.M, Pillai G.C, Mouksassi S, Steffens B, Bräm D, Sprecher V, Hofmann D, Buettcher M, Coulibaly J.T, Ali S.M, Keiser J, Pfister M. Pharmacometric analysis to describe pharmacokinetics and exposure-efficacy response of ivermectin in adolescents infected with Trichuris trichiura. J Clin Pharmacol. 2024(in press). DOI: 10.1002/jcph.6158

2024
Journal Article
PubMed

Cesar-Rodo E, Dupouy B, Häberli C, Strub J.M, Williams D.L, Mäser P, Rottmann M, Keiser J, Lanfranchi D.A, Davioud-Charvet E. Regioselective synthesis of potential non-quinonoid prodrugs of plasmodione: antiparasitic properties against two hemoglobin-feeding parasites and drug metabolism studies. Molecules. 2024;29(22). DOI: 10.3390/molecules29225268

2024
Journal Article
PubMed

Davie T, Serrat X, Imhof L, Snider J, Štagljar I, Keiser J, Hirano H, Watanabe N, Osada H, Fraser A.G. Identification of a family of species-selective complex I inhibitors as potential anthelmintics. Nat Commun. 2024;15:3367. DOI: 10.1038/s41467-024-47331-3

2024
Journal Article
PubMed

Dommann J, Keiser J, Garneau J, Gandelin A, Casanova C, Keller P.M, Sayasone S, Vonaesch P, Schneeberger P.H.H. Exposure of gut bacterial isolates to the anthelminthic drugs, ivermectin and moxidectin, leads to antibiotic-like phenotypes of growth inhibition and adaptation. Commun Biol. 2024;7:1566. DOI: 10.1038/s42003-024-07135-z

2024
Journal Article
PubMed

Dommann J, Kerbl-Knapp J, Albertos Torres D, Egli A, Keiser J, Schneeberger P.H.H. A novel barcoded nanopore sequencing workflow of high-quality, full-length bacterial 16S amplicons for taxonomic annotation of bacterial isolates and complex microbial communities. mSystems. 2024;9(10):e0085924. DOI: 10.1128/msystems.00859-24

2024
Journal Article
PubMed

Dupouy B, Karpstein T, Häberli C, Cal M, Rottmann M, Mäser P, Keiser J, Elhabiri M, Davioud-Charvet E. Synthesis of 1,2,3-triazole-methyl-menadione derivatives: evaluation of electrochemical and antiparasitic properties against two blood-dwelling parasites. ChemMedChem. 2024(in press). DOI: 10.1002/cmdc.202400731

2024
Journal Article
PubMed

Dziwornu G.A, Attram H.D, Häberli C, Masike K, Njoroge M, Keiser J. Benzimidazole analogues active against adult Schistosoma mansoni: SAR analyses, in vivo efficacy in mice, and preliminary mechanistic studies as potential inhibitors of hemozoin formation. Eur J Med Chem. 2024(in press). DOI: 10.1016/j.ejmech.2024.117186

2024
Journal Article
PubMed

Emerson P.M, Evans D, Freeman M.C, Hanson C, Kalua K, Keiser J, Krolewiecki A, Leonard L, Levecke B, Matendechero S, Means A.R, Montresor A, Mupfasoni D, Pullan R.L, Rotondo L.A, Stephens M, Sullivan K.M, Walson J.L, Williams T, Utzinger J. Need for a paradigm shift in soil-transmitted helminthiasis control: targeting the right people, in the right place, and with the right drug(s). PLoS Negl Trop Dis. 2024;18(10):e0012521. DOI: 10.1371/journal.pntd.0012521

2024
Journal Item
PubMed

Fuchs N, Zimmermann R.A, Schwickert M, Gunkel A, Zimmer C, Meta M, Schwickert K, Keiser J, Haeberli C, Kiefer W, Schirmeister T. Dual strategy to design new agents targeting Schistosoma mansoni: advancing phenotypic and SmCB1 inhibitors for improved efficacy. ACS Infect Dis. 2024;10(5):1664-1678. DOI: 10.1021/acsinfecdis.4c00020

2024
Journal Article
PubMed

González Cabrera D, Keiser J, Spangenberg T. Analysis of the physicochemical properties of anti-schistosomal compounds to identify next-generation leads. ACS Med Chem Lett. 2024;15(5):626-630. DOI: 10.1021/acsmedchemlett.4c00026

2024
Journal Item
PubMed

Gordon C.A, Utzinger J, Muhi S, Becker S.L, Keiser J, Khieu V, Gray D.J. Strongyloidiasis. Nat Rev Dis Primers. 2024;10:6. DOI: 10.1038/s41572-023-00490-x

2024
Journal Article
PubMed

Grolimund C.M, Utzinger J, Coulibaly J.T, Sayasone S, Ali S.M, Keiser J, Vounatsou P. Modeling transmission mechanism to infer treatment efficacy of different drugs and combination therapy against Trichuris trichiura. Sci Rep. 2024;14(1):23543. DOI: 10.1038/s41598-024-73164-7

2024
Journal Article
PubMed

Keiser J, Bouchery T. A step forward in the journey towards hookworm vaccines. Lancet Infect Dis. 2024;24(7):673-674. DOI: 10.1016/s1473-3099(24)00145-2

2024
Journal Item
PubMed

Kuevi D.N.O, Keiser J, Häberli C, Owusu-Senyah A.K, Ahiabu M.K. In vitro antischistosomal activity of Bridelia ferruginea, Clausena anisata, Khaya senegalensis, and Vernonia amygdalina. J Trop Med. 2024;2024:8074291. DOI: 10.1155/2024/8074291

2024
Journal Article
PubMed

Leas D.A, Keiser J, Charman S.A, Shackleford D.M, Jones J.O, Campbell M, Chen G, Katneni K, Patil R, Hu M, Pham T, Häberli C, Schulze T.T, Neville A.J, Wang X, Dong Y, Davis P.H, Vennerstrom J.L. Single-Dose Drug Development Candidate for Schistosomiasis. ACS Infect Dis. 2024;10(11):3963-3972. DOI: 10.1021/acsinfecdis.4c00677

2024
Journal Article
PubMed

Lo N.C, Addiss D.G, Buonfrate D, Amor A, Anegagrie M, Bisoffi Z, Bradbury R.S, Keiser J, Kepha S, Khieu V, Krolewiecki A, Mbonigaba J.B, Muñoz J, Mutapi F, Novela V, Vaz Nery S, Coffeng L.E, de Vlas S.J, Bartoszko J, Moja L, Mupfasoni D, Montresor A. Review of the WHO guideline on preventive chemotherapy for public health control of strongyloidiasis. Lancet Infect Dis. 2024(in press). DOI: 10.1016/s1473-3099(24)00595-4

2024
Journal Article
PubMed

Lotz C.N, Krollenbrock A, Imhof L, Riscoe M, Keiser J. Robenidine derivatives as potential antischistosomal drug candidates. Int J Parasitol Drugs Drug Resist. 2024;25:100546. DOI: 10.1016/j.ijpddr.2024.100546

2024
Journal Article
PubMed

Palmeirim M.S, Hürlimann E, Beinamaryo P, Kyarisiima H, Nabatte B, Hattendorf J, Steinmann P, Keiser J. Efficacy and safety of albendazole alone versus albendazole in combination with ivermectin for the treatment of Trichuris trichiura infections: an open-label, randomized controlled superiority trial in south-western Uganda. PLoS Negl Trop Dis. 2024;18(11):e0012687. DOI: 10.1371/journal.pntd.0012687

2024
Journal Article
PubMed

Pillay-Fuentes Lorente V, Nwogu-Attah J.N, Steffens B, Bräm D, Sprecher V, Hofmann D, Buettcher M, Pillai G, Mouksassi S, Coulibaly J, Pfister M, Keiser J. Understanding drug exposure and Trichuris trichiura cure rates: a pharmacometric approach for albendazole-ivermectin co-medication in Tanzania and Côte d'Ivoire. Drugs R D. 2024;24(2):331-340. DOI: 10.1007/s40268-024-00476-4

2024
Journal Article
PubMed

Qian M.B, Keiser J, Utzinger J, Zhou X.N. Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control. Clin Microbiol Rev. 2024;37(1):e0000923. DOI: 10.1128/cmr.00009-23

2024
Journal Article
PubMed

Ren R, Leas D.A, Häberli C, Cal M, Chen G, Katneni K, Dong Y, Kaiser M, Keiser J, Charman S.A, Vennerstrom J.L. Medium-ring keto bislactams with antischistosomal activity. J Med Chem. 2024;67(20):18235-18246. DOI: 10.1021/acs.jmedchem.4c01532

2024
Journal Article
PubMed

Shanley H.T, Taki A.C, Nguyen N, Wang T, Byrne J.J, Ang C.S, Leeming M.G, Nie S, Williamson N, Zheng Y, Young N.D, Korhonen P.K, Hofmann A, Chang B.C.H, Wells T.N.C, Häberli C, Keiser J, Jabbar A, Sleebs B.E, Gasser R.B. Structure-activity relationship and target investigation of 2-aryl quinolines with nematocidal activity. Int J Parasitol Drugs Drug Resist. 2024;24:100522. DOI: 10.1016/j.ijpddr.2024.100522

2024
Journal Article
PubMed

Sprecher V.P, Hofmann D, Savathdy V, Xayavong P, Norkhankhame C, Huy R, Khieu V, Sayasone S, Hattendorf J, Keiser J. Efficacy and safety of moxidectin compared with ivermectin against Strongyloides stercoralis infection in adults in Laos and Cambodia: a randomised, double-blind, non-inferiority, phase 2b/3 trial. Lancet Infect Dis. 2024;24(2):196-205. DOI: 10.1016/s1473-3099(23)00507-8

2024
Journal Article
PubMed

Stettler M, Lotz C, Probst A, Marreros N, Lundström-Stadelmann B, Frey C.F, Keiser J, Hofer A, Hoby S. Safety and pharmacokinetics of praziquantel in european pond turtles (Emys orbicularis). J Zoo Wildl Med. 2024;54(4):728-737. DOI: 10.1638/2023-0031

2024
Journal Article
PubMed

Taylor L, Ahmada A.A, Ali M.S, Ali S.M, Hattendorf J, Mohammed I.S, Keiser J. Efficacy and safety of emodepside compared with albendazole in adolescents and adults with hookworm infection in Pemba Island, Tanzania: a double-blind, superiority, phase 2b, randomised controlled trial. Lancet. 2024;404(10453):683-691. DOI: 10.1016/s0140-6736(24)01403-x

2024
Journal Article
PubMed

Vaillant M.T, Philippy F, Neven A, Barré J, Bulaev D, Olliaro P.L, Utzinger J, Keiser J, Garba A.T. Diagnostic tests for human Schistosoma mansoni and Schistosoma haematobium infection: a systematic review and meta-analysis. Lancet Microbe. 2024;5:e366-e378. DOI: 10.1016/s2666-5247(23)00377-4

2024
Journal Article
PubMed

van Beek A.E, Jeanguenat H, Häberli C, Pouw R.B, Lamers C, Pál G, Gál P, Schmidt C.Q, Ricklin D, Keiser J. Praziquantel and factor H recruitment differentially affect the susceptibility of Schistosoma mansoni to complement-mediated damage. Front Immunol. 2024;15:1474358. DOI: 10.3389/fimmu.2024.1474358

2024
Journal Article
PubMed

Welsche S, Schneeberger P.H.H, Hattendorf J, Sayasone S, Hürlimann E, Keiser J. Egg excretion patterns of soil-transmitted helminth infections in humans following albendazole-ivermectin and albendazole treatment. PLoS Negl Trop Dis. 2024;18(3):e0012073. DOI: 10.1371/journal.pntd.0012073

2024
Journal Article
PubMed

Biendl S, Häberli C, Chen G, Wang W, Zhong L, Saunders J, Pham T, Wang X, Wu J, Charman S.A, Vennerstrom J.L, Keiser J. In vitro and in vivo antischistosomal activity profiling and pharmacokinetics of ozonide carboxylic acids. ACS Infect Dis. 2023;9(3):643-652. DOI: 10.1021/acsinfecdis.2c00581

2023
Journal Article
PubMed

Brooker S.J, Keiser J, Bundy D.A.P. Soil-transmitted helminths (geohelminths). In: Farrar J,Hotez P.J,Junghanss T,Kang G,Lalloo D,White N.J,Garcia P.J, eds. Manson's Tropical Diseases, 772-796. Amsterdam: Elsevier, 2023. DOI: 10.1016/B978-0-7020-7959-7.00060-9

2023
Book Section

Cappuccino C, Spoletti E, Renni F, Muntoni E, Keiser J, Voinovich D, Perissutti B, Lusi M. Co-crystalline solid solution affords a high-soluble and fast-absorbing form of praziquantel. Mol Pharm. 2023;20(4):2009-2016. DOI: 10.1021/acs.molpharmaceut.2c00984

2023
Journal Article
PubMed

Coffeng L.E, Vlaminck J, Cools P, Denwood M, Albonico M, Ame S.M, Ayana M, Dana D, Cringoli G, de Vlas S.J, Fenwick A, French M, Kazienga A, Keiser J, Knopp S, Leta G, Matoso L.F, Maurelli M.P, Montresor A, Mirams G, Mekonnen Z, Corrêa-Oliveira R, Pinto S.A, Rinaldi L, Sayasone S, Steinmann P, Thomas E, Vercruysse J, Levecke B. A general framework to support cost-efficient fecal egg count methods and study design choices for large-scale STH deworming programs-monitoring of therapeutic drug efficacy as a case study. PLoS Negl Trop Dis. 2023;17(5):e0011071. DOI: 10.1371/journal.pntd.0011071

2023
Journal Article
PubMed

Coulibaly J.T, Silue K.D, Armstrong M, Díaz de León Derby M, D'Ambrosio M.V, Fletcher D.A, Keiser J, Fisher K, Andrews J.R, Bogoch I.I. High sensitivity of mobile phone microscopy screening for Schistosoma haematobium in Azaguié, Côte d'Ivoire. Am J Trop Med Hyg. 2023;108(1):41-43. DOI: 10.4269/ajtmh.22-0527

2023
Journal Article
PubMed

D'Abbrunzo I, Bianco E, Gigli L, Demitri N, Birolo R, Chierotti M.R, Škorić I, Keiser J, Häberli C, Voinovich D, Hasa D, Perissutti B. Praziquantel meets Niclosamide: a dual-drug antiparasitic cocrystal. Int J Pharm. 2023;644:123315. DOI: 10.1016/j.ijpharm.2023.123315

2023
Journal Article
PubMed

Easland E, Biendl S, Keiser J. Development of a hookworm egg hatching assay to determine the ovicidal effects of anthelminthics. Parasit Vectors. 2023;16:157. DOI: 10.1186/s13071-023-05771-8

2023
Journal Article
PubMed

Friedrich L, Park S.K, Ballard P, Ho Baeurle T.H, Maillard D, Bödding M, Keiser J, Marchant J.S, Spangenberg T. Metabolism of (R)-praziquantel versus the activation of a Parasite Transient Receptor Potential Melastatin ion channel. ChemMedChem. 2023;18(18):e202300140. DOI: 10.1002/cmdc.202300140

2023
Journal Article
PubMed

Hürlimann E, Hofmann D, Keiser J. Ivermectin and moxidectin against soil-transmitted helminth infections. Trends Parasitol. 2023;39(4):272-284. DOI: 10.1016/j.pt.2023.01.009

2023
Journal Article
PubMed

Kasago F.M, Häberli C, Keiser J, Masamba W. Design, synthesis and evaluation of praziquantel analogues and new molecular hybrids as potential antimalarial and anti-schistosomal agents. Molecules. 2023;28(13):5184. DOI: 10.3390/molecules28135184

2023
Journal Article
PubMed

Keiser J. Present drugs and future perspectives in treating soil-transmitted helminthiasis. Front Trop Dis. 2023;4:1282725. DOI: 10.3389/fitd.2023.1282725

2023
Journal Article

Mäser P, Bernhard S, Brun R, Burri C, Gagneux S, Hetzel M.W, Kaiser M, Lengeler C, Pluschke G, Reus E, Rottmann M, Utzinger J, Warryn L, Wittlin S, Keiser J. Key contributions by the Swiss Tropical and Public Health Institute towards new and better drugs for tropical diseases. Chimia (Aarau). 2023;77(9):593-606. DOI: 10.2533/chimia.2023.593

2023
Journal Article
PubMed

Meier L, Antillón M, Burri C, Chitnis N, Endriss Y, Keiser J, Moore S, Müller P, Penny M, Voss T.S, Mäser P, Utzinger J. Repurposing know-how for drug development: case studies from the Swiss Tropical and Public Health Institute. Chimia (Aarau). 2023;77(9):582-592. DOI: 10.2533/chimia.2023.582

2023
Journal Article
PubMed

Mrimi E.C, Palmeirim M.S, Minja E.G, Long K.Z, Keiser J. Correlation of cytokines with parasitic infections, undernutrition and micronutrient deficiency among schoolchildren in rural Tanzania: a cross-sectional study. Nutrients. 2023;15(8):1916. DOI: 10.3390/nu15081916

2023
Journal Article
PubMed

Mrimi E.C, Welsche S, Ali S.M, Hattendorf J, Keiser J. Emodepside for Trichuris trichiura and hookworm infection. N Engl J Med. 2023;388(20):1863-1875. DOI: 10.1056/NEJMoa2212825

2023
Journal Article
PubMed

Muya K, Kalonji M, Ilunga N.W, Maseho M, Kitambala M, Kalonda M, Ndoumba K, Byanga K, Wright C.W, Häberli C, Keiser J, Simbi L. Evaluation of 43 species of Congolese medicinal plants used traditionally for the treatment of schistosomiasis leading to the isolation of an anti-schistosomal phaeophytin from Pseudolachnostylis maprouneifolia Pax. J Ethnopharmacol. 2023;315:116688. DOI: 10.1016/j.jep.2023.116688

2023
Journal Article
PubMed

Noce B, Di Bello E, Zwergel C, Fioravanti R, Valente S, Rotili D, Masotti A, Ansari M.S.Z, Trisciuoglio D, Chakrabarti A, Romier C, Robaa D, Sippl W, Jung M, Häberli C, Keiser J, Mai A. Chemically diverse S. mansoni HDAC8 inhibitors reduced viability in worm larval and adult stages. ChemMedChem. 2023;18(3):e202200510. DOI: 10.1002/cmdc.202200510

2023
Journal Article
PubMed

Radulov P.S, Yaremenko I.A, Keiser J, Terent'ev A.O. Bridged 1,2,4-trioxolanes: SnCl4-catalyzed synthesis and an in vitro study against S. mansoni. Molecules. 2023;28(13). DOI: 10.3390/molecules28134913

2023
Journal Article
PubMed

Schärer A, Biendl S, Keiser J. Trichuris muris egg-hatching assay for anthelminthic drug discovery and characterization. Int J Parasitol Drugs Drug Resist. 2023;23:63-70. DOI: 10.1016/j.ijpddr.2023.10.001

2023
Journal Article
PubMed

Specht S, Keiser J. Helminth infections: enabling the World Health Organization road map. Int J Parasitol. 2023;53(8):411-414. DOI: 10.1016/j.ijpara.2022.10.006

2023
Journal Article
PubMed

Sprecher V.P, Coulibaly J.T, Hürlimann E, Hattendorf J, Keiser J. Efficacy and safety of moxidectin-albendazole and ivermectin-albendazole combination therapy compared to albendazole monotherapy in adolescents and adults infected with Trichuris trichiura: a randomized controlled superiority trial. Clin Infect Dis. 2023;77(9):1294-1302. DOI: 10.1093/cid/ciad387

2023
Journal Article
PubMed

Welsche S, Mrimi E.C, Hattendorf J, Hürlimann E, Ali S.M, Keiser J. Efficacy and safety of moxidectin and albendazole compared with ivermectin and albendazole coadministration in adolescents infected with Trichuris trichiura in Tanzania: an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. Lancet Infect Dis. 2023;23(3):331-340. DOI: 10.1016/S1473-3099(22)00589-8

2023
Journal Article
PubMed

Angeli A, Ferraroni M, Carta F, Häberli C, Keiser J, Costantino G, Supuran C.T. Development of praziquantel sulphonamide derivatives as antischistosomal drugs. J Enzyme Inhib Med Chem. 2022;37(1):1479-1494. DOI: 10.1080/14756366.2022.2078970

2022
Journal Article
PubMed

Biendl S, Häberli C, Keiser J. Discovery of novel antischistosomal scaffolds from the open access Pandemic Response Box. Expert Rev Anti Infect Ther. 2022;20(4):621-629. DOI: 10.1080/14787210.2022.1990042

2022
Journal Article
PubMed

Cantara A, Luo Y, Dobrovolna M, Bohalova N, Fojta M, Verga D, Guittat L, Cucchiarini A, Savrimoutou S, Häberli C, Guillon J, Keiser J, Brazda V, Mergny J.L. G-quadruplexes in helminth parasites. Nucleic Acids Res. 2022;50(5):2719-2735. DOI: 10.1093/nar/gkac129

2022
Journal Article
PubMed

Coulibaly J.T, Hürlimann E, Patel C, Silué D.K, Avenié D.J, Kouamé N.A, Silué U.M, Keiser J. Optimizing implementation of preventive chemotherapy against soil-transmitted helminthiasis and intestinal schistosomiasis using high-resolution data: field-based experiences from Côte d'Ivoire. Diseases. 2022;10(4):66. DOI: 10.3390/diseases10040066

2022
Journal Article
PubMed

Di Bello E, Noce B, Fioravanti R, Zwergel C, Valente S, Rotili D, Fianco G, Trisciuoglio D, Mourão M.M, Sales P. Jr, Lamotte S, Prina E, Späth G.F, Häberli C, Keiser J, Mai A. Effects of structurally different HDAC inhibitors against Trypanosoma cruzi, Leishmania, and Schistosoma mansoni. ACS Infect Dis. 2022;8(7):1356-1366. DOI: 10.1021/acsinfecdis.2c00232

2022
Journal Article
PubMed

Dube M, Llanes D, Saoud M, Rennert R, Imming P, Häberli C, Keiser J, Arnold N. Albatrellus confluens (Alb. & Schwein.) Kotl. & Pouz.: natural fungal compounds and synthetic derivatives with in vitro anthelmintic activities and antiproliferative effects against two human cancer cell lines. Molecules. 2022;27(9):2950. DOI: 10.3390/molecules27092950

2022
Journal Article
PubMed

Dube M, Raphane B, Sethebe B, Seputhe N, Tiroyakgosi T, Imming P, Häberli C, Keiser J, Arnold N, Andrae-Marobela K. Medicinal plant preparations administered by Botswana traditional health practitioners for treatment of worm infections show anthelmintic activities. Plants (Basel). 2022;11(21):2945. DOI: 10.3390/plants11212945

2022
Journal Article
PubMed

Falcoz C, Guzy S, Kovač J, Meister I, Coulibaly J, Sayasone S, Wesche D, Lin Y.W, Keiser J. R-praziquantel integrated population pharmacokinetics in preschool- and school-aged African children infected with Schistosoma mansoni and S. haematobium and Lao adults infected with Opisthorchis viverrini. J Pharmacokinet Pharmacodyn. 2022;49(3):293-310. DOI: 10.1007/s10928-021-09791-8

2022
Journal Article
PubMed

Falcoz C, Guzy S, Kovac J, Meister I, Coulibaly J, Sayasone S, Wesche D, Lin Y.W, Keiser J. Correction to: R-praziquantel integrated population pharmacokinetics in preschool- and school-aged African children infected with Schistosoma mansoni and S. haematobium and Lao adults infected with Opisthorchis viverrini. J Pharmacokinet Pharmacodyn. 2022;49(3):395. DOI: 10.1007/s10928-022-09807-x

2022
Journal Item
PubMed

Grolimund C.M, Bärenbold O, Utzinger J, Keiser J, Vounatsou P. Modeling the effect of different drugs and treatment regimen for hookworm on cure and egg reduction rates taking into account diagnostic error. PLoS Negl Trop Dis. 2022;16(10):e0010810. DOI: 10.1371/journal.pntd.0010810

2022
Journal Article
PubMed

Hamway Y, Zimmermann K, Blommers M.J.J, Sousa M, Häberli C, Kulkarni S, Skalicky S, Hackl M, Götte M, Keiser J, da Costa C.P, Spangenberg T, Azzaoui K. Modulation of host-parasite interactions with small molecules targeting Schistosoma mansoni microRNAs. ACS Infect Dis. 2022;8:2028−2034. DOI: 10.1021/acsinfecdis.2c00360

2022
Journal Item
PubMed

Harrington S, Knox J.J, Burns A.R, Choo K.L, Au A, Kitner M, Häberli C, Pyche J, D'Amata C, Kim Y.H, Volpatti J.R, Guiliani M, Snider J, Wong V, Palmeira B.M, Redman E.M, Vaidya A.S, Gilleard J.S, Stagljar I, Cutler S.R, Kulke D, Dowling J.J, Yip C.M, Keiser J, Zasada I, Lautens M, Roy P.J. Egg-laying and locomotory screens with C. elegans yield a nematode-selective small molecule stimulator of neurotransmitter release. Commun Biol. 2022;5:865. DOI: 10.1038/s42003-022-03819-6

2022
Journal Article
PubMed

Hassan M.M, Sedighi A, Olaoye O.O, Häberli C, Merz A, Ramos-Morales E, de Araujo E.D, Romier C, Jung M, Keiser J, Gunning P.T. Phenotypic screening of histone deacetylase (HDAC) inhibitors against Schistosoma mansoni. ChemMedChem. 2022:e202100622. DOI: 10.1002/cmdc.202100622

2022
Journal Article
PubMed

Herath H.M.P.D, Taki A.C, Rostami A, Jabbar A, Keiser J, Geary T.G, Gasser R.B. Whole-organism phenotypic screening methods used in early-phase anthelmintic drug discovery. Biotechnol Adv. 2022;57:107937. DOI: 10.1016/j.biotechadv.2022.107937

2022
Journal Article
PubMed

Hofmann D, Brussee J.M, Schulz J.D, Coulibaly J.T, Pfister M, Keiser J. Pharmacokinetic modelling and simulation to optimize albendazole dosing in hookworm- or Trichuris trichiura-infected infants to adults. J Antimicrob Chemother. 2022;77(4):1082-1093. DOI: 10.1093/jac/dkac020

2022
Journal Article
PubMed

Hofmann D, Smit C, Sayasone S, Pfister M, Keiser J. Optimizing moxidectin dosing for Strongyloides stercoralis infections: insights from pharmacometric modeling. Clin Transl Sci. 2022;15(3):700-708. DOI: 10.1111/cts.13189

2022
Journal Article
PubMed

Hürlimann E, Keller L, Patel C, Welsche S, Hattendorf J, Ali S.M, Ame S.M, Sayasone S, Coulibaly J.T, Keiser J. Efficacy and safety of co-administered ivermectin and albendazole in school-aged children and adults infected with Trichuris trichiura in Côte d'Ivoire, Laos, and Pemba Island, Tanzania: a double-blind, parallel-group, phase 3, randomised control. Lancet Infect Dis. 2022;22(1):123-135. DOI: 10.1016/S1473-3099(21)00421-7

2022
Journal Article
PubMed

Kersting L, Kuhn L, Anokhin M, Schuster F, Häberli C, Sambyal S, Kumar H.M.S, Keiser J, Alabugin I, Tsogoeva S.B. Visible-light-driven metal-free C-H functionalization: access to new bioactive tetrahydroisoquinoline-butenolide hybrids via domino amine oxidation/vinylogous Mannich reaction. ChemPhotoChem. 2022;6(8):e202200109. DOI: 10.1002/cptc.202200109

2022
Journal Article

Mrimi E.C, Palmeirim M.S, Minja E.G, Long K.Z, Keiser J. Malnutrition, anemia, micronutrient deficiency and parasitic infections among schoolchildren in rural Tanzania. PLoS Negl Trop Dis. 2022;16(3):e0010261. DOI: 10.1371/journal.pntd.0010261

2022
Journal Article
PubMed

Olliaro P.L, Vaillant M.T, Diawara A, Speich B, Albonico M, Utzinger J, Keiser J. Egg excretion indicators for the measurement of soil-transmitted helminth response to treatment. PLoS Negl Trop Dis. 2022;16(8):e0010593. DOI: 10.1371/journal.pntd.0010593

2022
Journal Article
PubMed

Probst A, Biendl S, Keiser J. Improving translational power in antischistosomal drug discovery. Adv Parasitol. 2022;117:47-73. DOI: 10.1016/bs.apar.2022.05.002

2022
Journal Article
PubMed

Probst A, Hofmann D, Fedorova O.S, Mazeina S.V, Sokolova T.S, Golovach E, Keiser J. Pharmacokinetics of ascending doses of praziquantel in adults infected with Opisthorchis felineus in Western Siberia, Russian Federation. Antimicrob Agents Chemother. 2022;66(10):e00526-22. DOI: 10.1128/aac.00526-22

2022
Journal Article
PubMed

Qian M.B, Patel C, Palmeirim M.S, Wang X, Schindler C, Utzinger J, Zhou X.N, Keiser J. Efficacy of drugs against clonorchiasis and opisthorchiasis: a systematic review and network meta-analysis. Lancet Microbe. 2022;3(8):e616-e624. DOI: 10.1016/S2666-5247(22)00026-X

2022
Journal Article
PubMed

Ravaynia P.S, Biendl S, Grassi F, Keiser J, Hierlemann A, Modena M.M. Real-time and automated monitoring of antischistosomal drug activity profiles for screening of compound libraries. iScience. 2022;25(4):104087. DOI: 10.1016/j.isci.2022.104087

2022
Journal Article
PubMed

Ren R, Wang X, Leas D.A, Häberli C, Cal M, Dong Y, Kaiser M, Keiser J, Vennerstrom J.L. Antischistosomal tetrahydro-γ-carboline sulfonamides. Bioorg Med Chem Lett. 2022;59:128546. DOI: 10.1016/j.bmcl.2022.128546

2022
Journal Article
PubMed

Schneeberger P.H.H, Gueuning M, Welsche S, Hürlimann E, Dommann J, Häberli C, Frey J.E, Sayasone S, Keiser J. Different gut microbial communities correlate with efficacy of albendazole-ivermectin against soil-transmitted helminthiases. Nat Commun. 2022;13:1063. DOI: 10.1038/s41467-022-28658-1

2022
Journal Article
PubMed

Smit C, Hofmann D, Sayasone S, Keiser J, Pfister M. Characterization of the population pharmacokinetics of moxidectin in adults infected with Strongyloides stercoralis: support for a fixed-dose treatment regimen. Clin Pharmacokinet. 2022;61:123-132. DOI: 10.1007/s40262-021-01048-4

2022
Journal Article
PubMed

Taki A.C, Wang T, Nguyen N.N, Ang C.S, Leeming M.G, Nie S, Byrne J.J, Young N.D, Zheng Y, Ma G, Korhonen P.K, Koehler A.V, Williamson N.A, Hofmann A, Chang B.C.H, Häberli C, Keiser J, Jabbar A, Sleebs B.E, Gasser R.B. Thermal proteome profiling reveals Haemonchus orphan protein HCO_011565 as a target of the nematocidal small molecule UMW-868. Front Pharmacol. 2022;13:1014804. DOI: 10.3389/fphar.2022.1014804

2022
Journal Article
PubMed

Taljaard L, Probst A, Tornow R, Keiser J, Haynes R.K, van der Kooy F. In vitro antischistosomal activity of Artemisia annua and Artemisia afra extracts. Phytomed Plus. 2022;2(3):100279. DOI: 10.1016/j.phyplu.2022.100279

2022
Journal Article